Stefan von Berg Selected Research

Enzymes

11/2012

Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan von Berg Research Topics

Disease

4	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2016
4	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 11/2012
1	Inflammation (Inflammations) 01/2021
1	Neoplasms (Cancer) 01/2019
1	Amyloid Plaque 01/2015

Drug/Important Bio-Agent (IBA)

2	Amyloid (Amyloid Fibrils)IBA 01/2015 - 11/2012
2	AZD3839IBA 11/2012 - 11/2012
1	Interleukin-22 (IL-22)IBA 01/2021
1	Imiquimod (Aldara)FDA LinkGeneric 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	compound 20IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016
1	Peptides (Polypeptides)IBA 01/2015
1	PyrazinesIBA 11/2012
1	Proteins (Proteins, Gene)FDA Link 11/2012
1	Glycogen Synthase (Synthase I)IBA 11/2012
1	EnzymesIBA 11/2012

Therapy/Procedure

1	Therapeutics 01/2019